May 7, 2013
BRAND NAME DEFENDANTS: WYETH LLC, WYETH PHARMACEUTICALS INC., INDIVIDUALLY AND D/B/A ESI LEDERLE, INC., PFIZER, INC., SCHWARZ PHARMA, INC., N/K/A UCB, INC., SCHWARZ PHARMA AG, UCB GMBH D/B/A SCHWARZ PHARMA AG, ALAVEN PHARMACEUTICAL LLC, BAXTER HEALTHCARE CORPORATION, WOCKHARDT USA, LLC, AND MORTON GROVE PHARMACEUTICALS, INC. GENERIC DEFENDANTS: TEVA PHARMACEUTICALS USA, INC., INDIVIDUALLY AND D/B/A IVAX PHARMACEUTICALS, MUTUAL PHARMACEUTICAL COMPANY, INC., AND JOHN DOE DEFENDANTS.
The opinion of the court was delivered by: James C. Mahan United States District Judge
Pursuant to the Joint Stipulation of Voluntary Dismissal (Doc. No. 69), Plaintiff's claims and causes of action against all defendants are hereby dismissed with prejudice pursuant to Rule 41(a) of the Federal Rules of Civil Procedure.
IT IS SO ORDERED.
© 1992-2013 VersusLaw Inc.